For the second quarter of the fiscal year ending March 2027, consolidated revenue was 28,485 million yen (Year-over-Year +9.3%), operating income was 947 million yen (Year-over-Year -44.7%), profit before tax for the interim period was 446 million yen, and net loss attributable to owners of the parent was -101 million yen. Full-year forecasts remain unchanged from the previously announced guidance. By segment, medical institutions saw revenue growth, hospice reduced losses, and home-visit nursing increased revenue but continued to be affected by initial costs of new bases. Total assets were 100,838 million yen, total liabilities were 66,747 million yen, and total equity was 33,763 million yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9158","jir_company_name":"CUC Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/9158-20261029-01.pdf","jir_short_summary":"For the second quarter of the fiscal year ending March 2027, consolidated revenue was 28,485 million yen (Year-over-Year +9.3%), operating income was 947 million yen (Year-over-Year -44.7%), profit before tax for the interim period was 446 million yen, and net loss attributable to owners of the parent was -101 million yen. Full-year forecasts remain unchanged from the previously announced guidance. By segment, medical institutions saw revenue growth, hospice reduced losses, and home-visit nursing increased revenue but continued to be affected by initial costs of new bases. Total assets were 100,838 million yen, total liabilities were 66,747 million yen, and total equity was 33,763 million yen.","jir_summary":"### Overview of Results\nFor the interim period, consolidated revenue was 28,735 million yen (Year-over-Year +9.3%), returning to growth, while operating income declined significantly to 947 million yen (Year-over-Year -44.7%). Profit before tax also fell substantially to 446 million yen, and net loss attributable to owners of the parent was -101 million yen. By segment, increased sales at medical institutions contributed positively; the hospice segment avoided an expansion of losses due to effects from new facility openings and drug price impacts; and home-visit nursing continued to be affected by upfront costs to build an expanded operating base. Going forward, optimizing the financial structure and improving facility utilization rates will be focal points.\n\n### Outlook and Capital Position\nThe consolidated outlook for the fiscal year ending March 2027 remains unchanged from the previously announced forecast. Total assets increased from the end of the previous fiscal year, mainly reflecting an increase in goodwill and assets related to acquisitions of overseas businesses. The impact of higher borrowings on financial expenses is also a point to monitor. Going forward, the company aims to improve profitability by expanding revenue opportunities through overseas base expansion while implementing phased cost reductions and enhancing PMI support effects.","jir_financial_highlights":"Revenue: 28,735 (Year-over-Year +9.3%)\nOperating Income: 947 (Year-over-Year -44.7%)\nProfit Before Tax (Interim): 446 (Year-over-Year -68.1%)\nNet Income Attributable to Owners of Parent (Interim): -101 (Year-over-Year -significant decrease)\nTotal Assets: 100,838","jir_category":"","jir_hashtags":"#CUC, #Earnings, #InterimResults, #MedicalInstitutionServices, #OverseasOperations","jir_key_figures":"Revenue: 28,735 million yen (Year-over-Year +9.3%)\nOperating Income: 947 million yen (Year-over-Year -44.7%)\nNet Income Attributable to Owners of Parent (Interim): -101 million yen","jir_meta_title":"CUC Inc. Second Quarter FY2027 Financial Summary | Revenue +9.3%, Operating Income Declines Significantly","jir_meta_description":"Summary of CUC Inc.'s second quarter results for the fiscal year ending March 2027. Revenue was 28,735 million yen (Year-over-Year +9.3%), operating income was 947 million yen (Year-over-Year -44.7%). Segment trends and financial position are analyzed.","jir_og_title":"CUC Inc. | Second Quarter FY2027 Financial Summary","jir_og_description":"CUC Inc.'s Q2 results: revenue rose while operating income fell significantly. Segment performance and outlook summarized.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57503,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-136685","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n